A survey investigating United States federal grant submissions proposing to investigate therapeutic applications of psychedelics
Barnett, B.
Show abstract
This study surveyed researchers to assess the contents and funding success of federal grant applications for research into therapeutic applications of psychedelics in the United States. The author emailed an anonymous survey to the corresponding authors of the 50 most-cited articles on psychedelics published after 2000 and disseminated it via Twitter. Ten researchers responded, reporting on 24 grant submissions for psilocybin, ibogaine, LSD, MDMA, and other psychedelics, all to the National Institutes of Health (NIH), from the early 1990s onward. The number of grant applications rose noticeably starting in 2006. Of all grant applications assessed,16.7% were funded, lower than the NIHs 23.4% average funding rate for R-01 equivalent grants between 1998-2023. More specifically, while no relevant grant applications submitted prior to 2006-2010 were funded by NIH, the funding rate of applications since then, estimated at 19.05% to 22.2%, is close to the average annual NIH funding rate of 20.6 {+/-} 1.9% for R-01 equivalent grant applications from 2006 to early 2023. Respondents generally believed applications for this line of research had a lower chance of success compared to other lines of research, although they felt the funding landscape has improved in recent years, in line with this studys other findings.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Sequential Bilateral Accelerated Theta Burst Stimulation in Adolescents With Suicidal Ideation Associated With Major Depressive Disorder: Protocol for a Randomized Controlled Trial 93%
- Social media discourse and internet search queries on cannabis as a medicine: A systematic review 93%
- Investigating experiences of stigma and its impact on substance use recovery among residents of recovery residences in the United States: A scoping review protocol. BSGH 020 93%
Similar papers in this journal
- A Methodological Checklist for fMRI Drug Cue Reactivity Studies: Development and Expert Consensus 93%
- A Checklist for Assessing the Methodological Quality of Concurrent tES-fMRI Studies (ContES Checklist): A Consensus Study and Statement 82%
- Generation and biobanking of patient-derived glioblastoma organoids and their application in CAR-T cell testing 82%
Similar papers in this journal
- Psychedelic mushrooms in the USA: Knowledge, patterns of use and association with health outcomes 93%
- Development of Goal Management Training + (GMT + ) for Methamphetamine Use Disorder Through Collaborative Design: A Process Description 92%
- Attitude towards Mental Help-Seeking, Motivation, and Economic Resources in Connection with Positive, Negative, and General Psychopathological Symptoms of Schizophrenia: A Pilot Study of a Psychoeducation Program 91%
Similar papers in this journal
- Symptom Monitoring based on Digital Data Collection During Inpatient Treatment of Schizophrenia Spectrum Disorders – a Feasibility Study 91%
- Development, validation and clinical utility of Short-term AdVerse-effects of Electroconvulsive therapy (SAVE) Checklist 91%
- Cost-effectiveness analysis comparing repetitive transcranial magnetic stimulation therapy with antidepressant treatment in patients with treatment-resistant depression in Japan 91%
Similar papers in this journal
- Uncovering the compounding effects of COVID-19 and racism on mental health disparities among biomedical PhD and MD students 93%
- Addressing cultural and knowledge barriers to enable preclinical sex inclusive research 90%
- An Experimental Test of the Effects of Redacting Grant Applicant Identifiers on Peer Review Outcomes 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.